CapitalStars Financial Research Pvt Ltd


CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market.we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors.we provide intraday as well as delivery stock tips in NSE and BSEand commodity tips in MCX and NCDEX. Read More

Commodity Market Services

Commodity Market Services

In this service we provide 3-4 intraday calls in MCX with a high level of accuracy. The calls are given in Precious Metals, Base Metals and Energies. You can also avail Free Tips for two days to test our accuracy and if satisfied you can join the services with Capital Stars. Read More

Nifty Market Services

Nifty Future Services

We provide you around 1-2 nifty calls, Bank Nifty Futures, nifty futures tips, sgx nifty tips Daily. You can gain more profit, Get 2 days free trial calls. Read More

Equity Market Services

Equity Market Services

In this service we provide 2-4 intraday stock cash calls in NSE/BSE with a high level of accuracy.You can also avail Free Stock Tips for two days to test our accuracy and if satisfied you can join stock cash services with Capital Stars. Read More

Register now

CapitalStars provides Free Trial in Intraday as well as in Positional Services of Equity, Derivatives, and Commodities and Forex Markets. We provide recommendations in NSE, BSE, MCX, NCDEX, and MCX-SX etc. We render you enough entry and exit time in our calls so clients can easily maximize their profits. Read More

Monday, 3 April 2017

Indoco Remedies falls over 15% on import alert for Goa unit : 3 Apr 2017

Indoco Remedies tanked 16% to Rs 208.50, also its 52-week low on the National Stock Exchange (NSE) in early morning trade after the company said it has received a warning letter from the US health regulator for its Goa plant.

“The United States Food and Drug Administration (USFDA) had inspected the company's drug manufacturing facility in Goa from August 31, 2016 to September 4, 2016. As an outcome of this inspection, the facility received 6 observations in Form 483, which do not pertain to data integrity”, Indoco Remedies said in a filing to BSE.

Based on the review of compliance response, FDA accepted our response to 4 observations. However, FDA remains concerned with respect to 2 observations, pertaining to one specific product, for which we are contract manufacturer, for one of our customers and consequently we have received a warning letter from USFDA dated March 27, 2017, on Friday, it added.

The company said it is fully committed in resolving the issue and will respond at the earliest.

The company is also committed to its philosophy of highest quality in manufacturing, operations, systems integrity and cGMP culture. The company continues to supply products from the above mentioned facility to meet its obligations to customers and the patients in the United States of America, it added.

At 09:29 am; the stock was down 13% at Rs 216 on the NSE as compared to 0.31% rise in the Nifty 50 index. A combined 467,549 shares changed hands on the counter on NSE and BSE.

Looking for investment in Share Market, CapitalStars Financial Research Private Limited provides you best investments Tips in Share Market.It  daily provides intraday and Future calls.We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities.

Get more details here:-

Commodity Market Tips
Equity Tips
Share Market Tips

* Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
* CapitalStars Investment Adviser: SEBI Registration Number: INA000001647


Post a Comment